Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,000,000 | 7,517,000 | 8,726,000 | 3,625,000 | 13,852,000 |
| Marketable Securities | 260,000 | 11,413,000 | 10,377,000 | 16,133,000 | 4,962,000 |
| Receivables | 9,183,000 | 8,334,000 | 8,680,000 | 8,910,000 | 8,678,000 |
| Inventories | 7,886,000 | 7,175,000 | 6,779,000 | 6,880,000 | 6,997,000 |
| Other current assets | 2,785,000 | 2,471,000 | 2,392,000 | 2,594,000 | 2,747,000 |
| TOTAL | $32,114,000 | $36,910,000 | $36,954,000 | $38,142,000 | $37,236,000 |
| Non-Current Assets | |||||
| PPE Net | 10,841,000 | 10,764,000 | 10,315,000 | 10,733,000 | 11,347,000 |
| Investments And Advances | 2,555,000 | 2,554,000 | 2,491,000 | 2,580,000 | 2,906,000 |
| Intangibles | 59,932,000 | 60,945,000 | 60,556,000 | 62,480,000 | 64,489,000 |
| Other Non-Current Assets | 6,799,000 | 6,280,000 | 8,148,000 | 8,975,000 | 9,240,000 |
| TOTAL | $80,127,000 | $80,543,000 | $81,510,000 | $84,768,000 | $87,982,000 |
| Total Assets | $112,241,000 | $117,453,000 | $118,464,000 | $122,910,000 | $125,218,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,968,000 | 5,931,000 | 7,055,000 | 7,045,000 | 6,696,000 |
| Accounts payable and accrued liabilities | 5,426,000 | 5,146,000 | 4,693,000 | 4,969,000 | 5,083,000 |
| Other current liabilities | 14,938,000 | 14,795,000 | 13,475,000 | 12,929,000 | 15,178,000 |
| TOTAL | $30,549,000 | $28,656,000 | $28,160,000 | $27,646,000 | $29,807,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,396,000 | 20,244,000 | 19,732,000 | 22,232,000 | 22,796,000 |
| Other Non-Current Liabilities | 6,426,000 | 6,444,000 | 6,953,000 | 6,903,000 | 7,530,000 |
| TOTAL | $29,550,000 | $29,374,000 | $29,406,000 | $32,258,000 | $33,707,000 |
| Total Liabilities | $60,099,000 | $58,030,000 | $57,566,000 | $59,904,000 | $63,514,000 |
| Shareholders' Equity | |||||
| Common Shares | 842,000 | 890,000 | 890,000 | 890,000 | 901,000 |
| Retained earnings | 51,253,000 | 58,544,000 | 60,000,000 | 62,095,000 | 60,699,000 |
| Other shareholders' equity | 83,000 | 81,000 | 78,000 | 81,000 | 164,000 |
| TOTAL | $52,142,000 | $59,423,000 | $60,898,000 | $63,006,000 | $61,704,000 |
| Total Liabilities And Equity | $112,241,000 | $117,453,000 | $118,464,000 | $122,910,000 | $125,218,000 |